98%
921
2 minutes
20
Purpose: In interdisciplinary teams, members may take on responsibilities usually performed by others to enhance patient care. In the Rapid Access Palliative Radiotherapy Program, a dedicated radiation therapist (MRT[T]) participates in clinical assessments, team conferences, patient education, simulation, treatment delivery, and follow-up. The purpose of this study was to determine the feasibility of virtual simulation performed by an MRT(T) experienced in treating bone metastases within this specialized clinic.
Methods: After radiotherapy was planned by a radiation oncologist (RO) and administered, the 3-dimensional dataset was duplicated and anonymized. In a blinded fashion, patients were independently retrospectively simulated by one MRT(T) with access to the patient's clinical and radiological information. Resulting digitally reconstructed radiographs were compared with actual simulation films. Summary statistics were compiled to quantify differences in field size (FS) and isocenter placement.
Results: Twelve bone metastases were treated (6 spine, 4 hip, 2 shoulder) with either a direct posterior or parallel opposed arrangement. For 11 of the 12 sites, beam arrangements chosen by the MRT(T) and the RO were the same. Shielding was added to 3 of the 12 sites by the RO and 2 of the 12 by the MRT(T). For the sites with a similar field arrangement, there was no significant difference between mean blocked RO (133.6 cm [SD 52.6 cm]) and MRT(T) field sizes (129.3 cm [SD 47.4 cm]) (P = .52). On average, the MRT(T) plan resulted in 4.3 cm undercoverage compared with the treatment FS. Isocenter placement differed on average by 0.25 cm laterally, 0.02 cm anteriorly, and 0.15 cm inferiorly for MRT(T) versus RO fields. One of 11 sites virtually planned by the MRT(T) was a geographic miss of a soft-tissue mass.
Conclusions: In this study, an MRT(T) member of a dedicated interdisciplinary team piloted virtual simulation for bone metastases treatment. Although average FS and isocenter placement did not significantly differ, optimal radiotherapy of complex bone metastases likely requires a collaborative approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jmir.2009.12.003 | DOI Listing |
Int J Surg
September 2025
Department of Radiology, Sichuan Provincial People's Hospital East Sichuan Hospital&Dazhou First People's Hospital, Dazhou, China.
Cancer Manag Res
September 2025
The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, People's Republic of China.
Background: Lung cancer brain metastasis (LCBM) accounts for 40-50% of intracranial malignancies, with emerging evidence of alternative metastatic pathways circumventing the blood-brain barrier. Existing prognostic models lack validation in Asian populations and molecular stratification. This multicenter study aimed to develop a clinical nomogram integrating clinicopathological and molecular determinants for personalized LCBM management.
View Article and Find Full Text PDFIndian J Nucl Med
August 2025
Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Metastatic renal osteosarcoma is a rare entity. We report a case of a 52-year-old male postright nephrectomy status presented to us with metastatic renal osteosarcoma. 18-fluorine- fluorodeoxyglucose (F-FDG) avid lesions were seen in the right renal bed with extension to adjacent hepatic parenchyma.
View Article and Find Full Text PDFCureus
September 2025
Department of Medical Oncology, Faculty of Medicine, Pharmacy and Dental Medicine of Fez, University Sidi Mohamed Ben Abdellah, Hassan II University Hospital Center, Fez, MAR.
Introduction Breast cancer (BC) is the most common malignancy among women worldwide and the leading cause of cancer-related mortality in women in Morocco. However, there is limited evidence on survival outcomes and treatment patterns among elderly patients with metastatic breast cancer (MBC) in this setting. Methods We conducted a retrospective cohort study at the Department of Medical Oncology, Hassan II University Hospital in Fez.
View Article and Find Full Text PDFCureus
August 2025
Division of Radiation Oncology and Developmental Radiotherapeutics, BC Cancer - Vancouver, Vancouver, CAN.
Introduction In select tumor sites, symptom palliation and local control can be improved through delivering higher biological equivalent doses (BED) of radiotherapy. However, not all patients are suitable candidates for stereotactic body radiation therapy (SBRT). The 30 Grays in five fractions (30/5) regimen is a conformal, hypofractionated regimen that offers a higher BED compared to conventional palliative radiotherapy.
View Article and Find Full Text PDF